Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intestinal Microbiota Transplant in Alcohol-Associated Chronic Liver Disease and Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

NCT05548452 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT05548452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05548452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intestinal Microbiota Transplant in Alcohol-Associated Chronic Liver Disease and Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Lead sponsor
Virginia Commonwealth University
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 21, 2022
Completion date
November 30, 2027
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, cirrhosis, liver disease; alcohol-related